Effect of Microbiome Modulation on Urinary Citrate and pH

Background: The gut microbiome plays an important role in the pathogenesis of urinary stone disease (USD), potentially through its influence on urinary components associated with stone formation. Changes in urinary pH and citrate levels are well established risk factors for USD. This study aims to determine the effects of microbiome suppression and subsequent restoration on urinary citrate concentration and pH, thereby elucidating the potential microbiome's contribution. Methods: Twenty-four male C57BL/6 mice were randomly assigned to receive placebo, sulfamethoxazole, or tylosin (n=8 per group). Baseline urine samples were collected over 24 hours prior to treatment initiation and again after one week of treatment. Antibiotics were subsequently discontinued, and the treated mice were co-housed with untreated mice for three weeks to allow microbiome restoration, after which a final urine sample was collected. Urinary citrate levels were measured using liquid chromatography–mass spectrometry (LC/MS) at the three timepoints, and urinary pH was assessed using a pH meter baseline and one week after antibiotic treatment. Results: Tylosin treatment significantly reduced urinary pH (6.72±0.35 to 5.93±0.34, p<0.01), whereas sulfamethoxazole had no significant effect (6.77±0.2 to 6.59±0.4, p=0.81) (Fig. 1). Urinary citrate excretion increased significantly in the sulfamethoxazole group (0.149±0.07 mg/24h to 0.404±0.16 mg/24h, p<0.01). Following co-housing with healthy mice, urinary citrate returned to its baseline value in both groups (Fig. 2). Conclusion: Antibiotic-induced suppression of the gut microbiome led to antibiotic-specific changes in urinary citrate levels and pH, both key factors influencing USD risk. Partial restoration of the healthy microbiome reversed these alterations in urinary citrate. Further studies are necessary to identify the specific bacterial species responsible for regulating urinary citrate excretion and acid-base balance. Funding: NIDDK Support

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025w88hh8ds
Primary Topic
Urinary Tract Infections Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of Microbiome Modulation on Urinary Citrate and pH

Karim Jaber, Rashmi Mishra, Xiaozhong Xiong, Amalya M. Charytan et al.
Journal of the American Society of Nephrology
Urinary Tract Infections Management
article

Effect of Microbiome Modulation on Urinary Citrate and pH

Karim Jaber, Rashmi Mishra, Xiaozhong Xiong, Amalya M. Charytan, Lama Nazzal, Kyle Merritts
article en

Abstract

Background: The gut microbiome plays an important role in the pathogenesis of urinary stone disease (USD), potentially through its influence on urinary components associated with stone formation. Changes in urinary pH and citrate levels are well established risk factors for USD. This study aims to determine the effects of microbiome suppression and subsequent restoration on urinary citrate concentration and pH, thereby elucidating the potential microbiome's contribution. Methods: Twenty-four male C57BL/6 mice were randomly assigned to receive placebo, sulfamethoxazole, or tylosin (n=8 per group). Baseline urine samples were collected over 24 hours prior to treatment initiation and again after one week of treatment. Antibiotics were subsequently discontinued, and the treated mice were co-housed with untreated mice for three weeks to allow microbiome restoration, after which a final urine sample was collected. Urinary citrate levels were measured using liquid chromatography–mass spectrometry (LC/MS) at the three timepoints, and urinary pH was assessed using a pH meter baseline and one week after antibiotic treatment. Results: Tylosin treatment significantly reduced urinary pH (6.72±0.35 to 5.93±0.34, p<0.01), whereas sulfamethoxazole had no significant effect (6.77±0.2 to 6.59±0.4, p=0.81) (Fig. 1). Urinary citrate excretion increased significantly in the sulfamethoxazole group (0.149±0.07 mg/24h to 0.404±0.16 mg/24h, p<0.01). Following co-housing with healthy mice, urinary citrate returned to its baseline value in both groups (Fig. 2). Conclusion: Antibiotic-induced suppression of the gut microbiome led to antibiotic-specific changes in urinary citrate levels and pH, both key factors influencing USD risk. Partial restoration of the healthy microbiome reversed these alterations in urinary citrate. Further studies are necessary to identify the specific bacterial species responsible for regulating urinary citrate excretion and acid-base balance. Funding: NIDDK Support

Journal of the American Society of NephrologyVol. 36(10S)
NYU Langone Health (US)
Openalex Percentile: Top 59%
Urinary Tract Infections Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.